Dorian O. Haskard
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Anti-Malondialdehyde Low-Density Lipoprotein Antibodies and Valvular Calcification: A Substudy of the SCOT-HEART Trial.
Journal: Journal of the American Heart Association
Published: November 03, 2025
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study.
Journal: American journal of respiratory and critical care medicine
Published: December 16, 2024
Impact of an Alu insertion on the cellular localisation of tissue factor protein.
Journal: Scientific reports
Published: October 30, 2024
Unlocking unknown mutations to understand causal relationships in cardiovascular science: paving the path to personalized cardiovascular care.
Journal: Cardiovascular research
Published: May 10, 2024
A novel translational model of atherosclerosis, the ex vivo pump-perfused amputated human limb model.
Journal: Scientific reports
Published: February 13, 2024
Chemical tools for profiling the intracellular ADP-ribosylated proteome.
Journal: RSC chemical biology
Published: February 08, 2024
Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 15, 2023
Cytokine-Mediated Degradation of the Transcription Factor ERG Impacts the Pulmonary Vascular Response to Systemic Inflammatory Challenge.
Journal: bioRxiv : the preprint server for biology
Published: February 17, 2023
Antimalondialdehyde Low-Density Lipoprotein Antibody Levels Predict Low-Attenuation Plaque in the SCOT-HEART Trial.
Journal: JACC. Cardiovascular imaging
Published: April 06, 2022
Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery.
Journal: Antioxidants (Basel, Switzerland)
Published: November 17, 2021
The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial.
Journal: Frontiers in cardiovascular medicine
Published: August 11, 2021
Last Updated: 09/26/2026